{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:51:47Z","timestamp":1793314307072,"version":"4.5.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess HPV vaccination coverage and cervical cancer screening participation among Iranian females under 46 years old, comparing Iran\u2019s situation to he Cervical Cancer Elimination Initiative (CCEI) targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This nationally and sub-nationally representative cross-sectional study analyzed data from the STEPS 2021 survey. Female participants aged 18\u201345 years without missing data on HPV vaccination or cervical cancer screening were included. Categorical data were presented as weighted percentages with 95% confidence intervals (95% CI). Logistic regression assessed associations between demographic and female cancer screening variables with the outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 8,158 females were included. Only 0.85% (95% CI: 0.69\u20131.02) of women received the HPV vaccine, while cervical cancer screening participation was 39.4% (95% CI: 38.21\u201340.6). No significant differences in HPV vaccination coverage were observed across age groups. However, screening rates were significantly higher in older women, rising from 27.99% (18\u201335 years) to 54.07% (36\u201345 years). HPV vaccination was not significantly associated with demographic variables. In contrast, cervical cancer screening participation was higher among unemployed women (40.58%), married women (49.6%), and those in the highest wealth quintile (42.47% compared to 28.29% in the lowest quintile).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HPV vaccination coverage in Iran is critically low, falling far short of the CCEI target of 90%. Cervical cancer screening participation is comparatively better but still lags approximately 30% behind the target. Strategic interventions are critical to bridge the gap between Iran\u2019s current status and the CCEI targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0341888","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:25:20Z","timestamp":1771525520000},"page":"e0341888","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3413-3373","authenticated-orcid":true,"given":"Mohammad","family":"Haddadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5192-0435","authenticated-orcid":true,"given":"Ali","family":"Golestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Farzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-3801","authenticated-orcid":true,"given":"Sina","family":"Azadnajafabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7460-6000","authenticated-orcid":true,"given":"Mohammad-Mahdi","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasserinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Yoosefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira Foroutan","family":"Mehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Hajebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar Mohammadi","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niusha","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Momen Nia Rankohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Djalalinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-4046","authenticated-orcid":true,"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"pone.0341888.ref001","unstructured":"Cervical cancer [Internet]. [cited 2024 Apr 7]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer"},{"key":"pone.0341888.ref002","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.552028","article-title":"Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation","volume":"8","author":"AJ Kombe","year":"2021","journal-title":"Front Public Health"},{"key":"pone.0341888.ref003","volume-title":"WHO cervical cancer elimination initiative: from call to action to global movement","author":"WH Organization","year":"2023"},{"key":"pone.0341888.ref004","unstructured":"Basic Information about HPV and Cancer | CDC [Internet]. 2023 [cited 2024 Apr 7]. Available from: https:\/\/www.cdc.gov\/cancer\/hpv\/basic_info\/index.htm"},{"issue":"1","key":"pone.0341888.ref005","first-page":"68","article-title":"Utilization evaluation of human papilloma virus vaccine (GARDASIL\u00ae) in Iran; a cross-sectional study","volume":"19","author":"F Mohammadpour","year":"2020","journal-title":"Iranian J Pharm Res"},{"key":"pone.0341888.ref006","unstructured":"CDC. HPV Vaccine Safety and Effectiveness Data [Internet]. Human Papillomavirus (HPV). 2024 [cited 2025 Jan 22]. Available from: https:\/\/www.cdc.gov\/hpv\/hcp\/vaccination-considerations\/safety-and-effectiveness-data.html"},{"key":"pone.0341888.ref007","unstructured":"eClinicalMedicine. Global strategy to eliminate cervical cancer as a public health problem: are we on track? eClinicalMedicine [Internet]. 2023 Jan 1 [cited 2025 Jan 6];55. Available from: https:\/\/www.thelancet.com\/journals\/eclinm\/article\/PIIS2589-5370(23)00019-6\/fulltext"},{"key":"pone.0341888.ref008","unstructured":"Cervical Cancer Elimination Initiative [Internet]. [cited 2025 Jan 6]. Available from: https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative"},{"issue":"7","key":"pone.0341888.ref009","article-title":"National and Subnational Trends of Incidence and Mortality of Female Genital Cancers in Iran; 1990-2016","volume":"23","author":"S Eftekharzadeh","year":"2020","journal-title":"Archives of Iranian Medicine (AIM) [Internet]"},{"issue":"11","key":"pone.0341888.ref010","first-page":"2313","article-title":"Cervical cancer prevention, its challenges and solutions in Iran and worldwide: a systematic review","volume":"52","author":"N Pirani","year":"2023","journal-title":"Iranian J Public Health"},{"issue":"1","key":"pone.0341888.ref011","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1186\/s12889-020-09705-2","article-title":"Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey","volume":"20","author":"R Amin","year":"2020","journal-title":"BMC Public Health"},{"key":"pone.0341888.ref012","first-page":"7","article-title":"Barriers and enablers to pharmacists\u2019 involvement in a novel immunisation programme","author":"AP Rathbone","year":"2022","journal-title":"Exploratory Research in Clinical and Social Pharmacy [Internet]"},{"issue":"8","key":"pone.0341888.ref013","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2471\/BLT.11.097253","article-title":"Achieving high coverage in Rwanda\u2019s national human papillomavirus vaccination programme","volume":"90","author":"A Binagwaho","year":"2012","journal-title":"Bullet World Health Organ"},{"issue":"9","key":"pone.0341888.ref014","doi-asserted-by":"crossref","first-page":"634","DOI":"10.34172\/aim.2022.99","article-title":"Protocol Design for Surveillance of Risk Factors of Non-communicable Diseases During the COVID-19 Pandemic: An Experience from Iran STEPS Survey 2021","volume":"25","author":"S Djalalinia","year":"2022","journal-title":"Arch Iran Med"},{"key":"pone.0341888.ref015","unstructured":"Human papillomavirus vaccines: WHO position paper, December 2022 [Internet]. [cited 2025 Jan 22]. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-wer9750-645-672"},{"issue":"4","key":"pone.0341888.ref016","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4103\/ijcm.IJCM_16_20","article-title":"Errors in the use of multivariable logistic regression analysis: an empirical analysis","volume":"45","author":"RK Malhotra","year":"2020","journal-title":"Indian J Community Med"},{"issue":"7621","key":"pone.0341888.ref017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.39339.610000.BE","article-title":"The Declaration of Helsinki","volume":"335","author":"MDE Goodyear","year":"2007","journal-title":"BMJ"},{"key":"pone.0341888.ref018","article-title":"Trends and Educational Differentials in Marriage Formation Among Taiwanese Women [Internet]","author":"YC Chang","year":"2011"},{"key":"pone.0341888.ref019","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biologicals.2020.08.007","article-title":"Optimized dose of synthetic analogues of Monophosphoryl lipid A as an effective alternative for formulating recombinant human papillomavirus vaccine","volume":"68","author":"A Azimi","year":"2020","journal-title":"Biologicals"},{"issue":"1","key":"pone.0341888.ref020","first-page":"2","article-title":"Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine","volume":"1","author":"KP Braaten","year":"2008","journal-title":"Rev Obstet Gynecol"},{"issue":"6","key":"pone.0341888.ref021","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/vaccines11061060","article-title":"Human papillomavirus epidemiology and prevention: is there still a gender gap?","volume":"11","author":"G Milano","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"pone.0341888.ref022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052016","article-title":"Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators","volume":"11","author":"J Spayne","year":"2021","journal-title":"BMJ Open"},{"key":"pone.0341888.ref023","unstructured":"Driving HPV Vaccination in Brazil [Internet]. The Vaccine Confidence Project. [cited 2024 May 20]. Available from: https:\/\/www.vaccineconfidence.org\/our-work\/projects\/driving-hpv-vaccination-in-brazil\/"},{"issue":"4","key":"pone.0341888.ref024","article-title":"Acceptance, Hesitancy, and Refusal Among Parents of Young Girls in Relation to Human Papillomavirus Vaccination: A Study From the Mohammed VI University Hospital Center in Oujda, Morocco","volume":"16","author":"H Elhaddadi","year":"2024","journal-title":"Cureus"},{"key":"pone.0341888.ref025","unstructured":"Human papillomavirus (HPV) vaccination coverage in adolescents in England: 2022 to 2023 [Internet]. GOV.UK. [cited 2024 May 20]. Available from: https:\/\/www.gov.uk\/government\/statistics\/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2022-to-2023\/human-papillomavirus-hpv-vaccination-coverage-in-adolescents-in-england-2022-to-2023"},{"key":"pone.0341888.ref026","unstructured":"HPV Vaccination Recommendations | CDC [Internet]. 2023 [cited 2024 Apr 5]. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/recommendations.html"},{"key":"pone.0341888.ref027","unstructured":"WHO updates recommendations on HPV vaccination schedule [Internet]. [cited 2024 May 20]. Available from: https:\/\/www.who.int\/news\/item\/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule"},{"key":"pone.0341888.ref028","unstructured":"WHO revises recommendations on lifesaving HPV vaccine | UN News [Internet]. 2022 [cited 2024 May 20]. Available from: https:\/\/news.un.org\/en\/story\/2022\/12\/1131897"},{"key":"pone.0341888.ref029","first-page":"225","article-title":"Cost-effectiveness evaluation of quadrivalent human papilloma virus vaccine for HPV-related disease in Iran","volume":"13","author":"M Khatibi","year":"2014","journal-title":"Iran J Pharm Res"},{"issue":"6","key":"pone.0341888.ref030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10935-022-00697-w","article-title":"Cost-Benefit Analysis of Human Papillomavirus Vaccine in Iran","volume":"43","author":"N Sargazi","year":"2022","journal-title":"J Prev (2022)"},{"key":"pone.0341888.ref031","unstructured":"New recommendations for screening and treatment to prevent cervical cancer [Internet]. [cited 2025 Jan 7]. Available from: https:\/\/www.who.int\/news\/item\/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer"},{"issue":"8","key":"pone.0341888.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309597","article-title":"Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review","volume":"19","author":"S Kisa","year":"2024","journal-title":"PLoS One"},{"issue":"5","key":"pone.0341888.ref033","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/jan.16653","article-title":"HPV vaccine hesitancy and uptake: a conceptual analysis using Rodgers\u2019 evolutionary approach","volume":"81","author":"GK Kyei","year":"2025","journal-title":"J Adv Nurs"},{"key":"pone.0341888.ref034","first-page":"73","article-title":"Improving HPV vaccination uptake among adolescents in low resource settings: sociocultural and socioeconomic barriers and facilitators","volume":"15","author":"MA Xu","year":"2024","journal-title":"Adolesc Health Med Ther"},{"key":"pone.0341888.ref035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/ijpvm.IJPVM_509_18","article-title":"Facilitating Factors and Barriers of Women\u2019s Cancer Screening in Iran: A Systematic Review","volume":"11","author":"S Ghahramani","year":"2020","journal-title":"Int J Prev Med"},{"issue":"1","key":"pone.0341888.ref036","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12889-024-17842-1","article-title":"Barriers to cervical cancer screening in Africa: a systematic review","volume":"24","author":"F Mantula","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0341888.ref037","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","article-title":"Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review","volume":"22","author":"Z Petersen","year":"2022","journal-title":"BMC Womens Health"},{"issue":"4","key":"pone.0341888.ref038","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jfprhc-2014-101082","article-title":"Barriers to cervical cancer screening among ethnic minority women: a qualitative study","volume":"41","author":"LAV Marlow","year":"2015","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"10224","key":"pone.0341888.ref039","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"K Canfell","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"pone.0341888.ref040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jwh.2015.5348","article-title":"Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability","volume":"25","author":"CS Racey","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"pone.0341888.ref041","unstructured":"Global strategy to accelerate the elimination of cervical cancer as a public health problem [Internet]. [cited 2025 Jan 7]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240014107"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:25:27Z","timestamp":1771525527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341888"}},"subtitle":[],"editor":[{"given":"Lucy W.","family":"Kivuti-Bitok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341888","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}